Showing results (121-130 of 293) with videos related to
Sort By:
Pageof 30
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2020
IntraOmmaya compartmental radioimmunotherapy using <sup>131</sup>I-omburtamab-pharmacokinetic modeling to optimize therapeutic indexRahul S Yerrabelli, Ping He, Edward K Fung, et al.Pediatric Blood & Cancer|September 7, 2022
Imaging of pediatric extremity soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White PaperMichael Richard Acord, Erika Pace, Alexander El-Ali, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion DosimetryNeeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [<sup>64</sup>Cu]Cu-NOTA-anti-CD8 PETVeronica L Nagle, Kelly E Henry, Charli Ann J Hertz, et al.International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.Leukemia Research|May 3, 2005
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucanShakeel Modak, Guenther Koehne, Andrew Vickers, et al.Journal of Pediatric Hematology/Oncology|August 18, 2017
Bevacizumab-associated Bowel Microperforation in a Patient With NeuroblastomaRachel Glincher, Anita P Price, Michael P LaQuaglia, et al.JCO Precision Oncology|July 10, 2025
Clinical Significance of <i>TERT</i> Promoter Mutations in NeuroblastomaNatasha Persaud, Gunes Gundem, Brian H Kushner, et al.Pageof 30